Nasal Esketamine

How Can Nasal Esketamine (Spravato) Help You?

Major depressive disorder can be a difficult condition to overcome, especially when you aren’t responding well to various antidepressants. Spravato is a medication that is used to assist those who struggle with treatment-resistant depression. It is delivered in the form of nasal spray and is self-administered in the presence of a trained and approved medical professional. It is designed to be used in conjunction with your regularly prescribed oral antidepressant. Many patients who have used Spravato for 16 weeks of therapy have indicated that their depression symptoms were reduced after four weeks when compared to patients who received a placebo or oral antidepressant alone. 

In March 2019, the U.S. Food and Drug Administration approved ketamine for the treatment of depression — the first new antidepressant medication in decades. Unlike previous generations of antidepressants, ketamine targets the neurotransmitter glutamate. And, a single dose can work in just a few hours and the effects persist for weeks.